It has been reported that DCLK1 (a putative marker for pancreatic and intestinal cancer stem cells) regulates EMT in human pancreatic cancer cells through a mechanism dependent on miR-200a [41]. This evidence concerns the gene DCLK1 and familial pancreatic carcinoma.